1. Home
  2. CCEL

CCEL

Cryo-Cell International Inc.

Logo Cryo-Cell International Inc.

Health Care

Managed Health Care

Nasdaq

as 04-18-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from cellular processing and cryogenic storage and it derives revenue from processing and testing fees and storage segment.

Founded: 1989 Country:
United States
United States
Employees: N/A City: OLDSMAR
Market Cap: 60.3M IPO Year: 1997
Target Price: N/A AVG Volume (30 days): 10.2K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.16 EPS Growth: N/A
52 Week Low/High: $3.45 - $8.15 Next Earning Date: 04-15-2024
Revenue: $31,371,515 Revenue Growth: 1.52%
Revenue Growth (this year): 3.67% Revenue Growth (next year): 10.72%

Share on Social Networks: